Showing results (251-260 of 1,198) with videos related to
Sort By:
Pageof 120
Blood|April 1, 1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemiaJ M Rowe, A Y Chang, J M BennettJournal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
Characterization of a CD40-dominant inhibitory receptor mutantA M Mehl, M Jones, M Rowe, et al.Expert Opinion on Pharmacotherapy|January 9, 2020
Pharmacological prophylaxis of infection in pediatric acute myeloid leukemia patientsNira Arad-Cohen, Jacob M Rowe, Yael Shachor-MeyouhasBritish Dental Journal|March 10, 2001
Prevalence, age of onset and demographic relationships of different areca nut habits amongst children in Tower Hamlets, LondonP Farrand, R M Rowe, A Johnston, et al.Therapeutic Drug Monitoring|October 10, 2001
Monitoring of busulfan area under the curve: estimation by a single measurementA Tabak, E Hoffer, J M Rowe, et al.Optics Express|March 30, 2011
Responsivity-based criterion for accurate calibration of FTIR emission spectra: theoretical development and bandwidth estimationPenny M Rowe, Steven P Neshyba, Von P WaldenAmerican Journal of Hematology|February 1, 1994
Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acidJ J Griggs, S E Henley, J M RoweJournal of Dental Research|February 1, 1989
Studies on sound and carious enamel with the quantitative acoustic microscopeS D Peck, J M Rowe, G A BriggsPediatric Pulmonology|March 1, 2018
Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducerJennifer S Guimbellot, Edward P Acosta, Steven M RoweBritish Journal of Pharmacology|December 11, 2008
Characterization of BK channel splice variants using membrane potential dyesF Saleem, I C M Rowe, M J ShipstonPageof 120